AOP

13.0 European CME credits (ECMEC®s) upon completion.
📅 April 10–11, 2026
This international Master Class will bring together physicians and experts from across Europe to explore the latest scientific and clinical advances in incretin-based therapies for type 2 diabetes and obesity.
👉 Register now: www.aop.am/conference

We are excited to announce an exceptional educational opportunity for physicians across Europe.
📅 April 10-11, 2026 📍 Yerevan
🔬 Why Attend? This CME-accredited Master Class brings together international experts to explore one of the most significant therapeutic advances in metabolic medicine. GLP-1 and dual agonist therapies are revolutionizing how we manage type 2 diabetes and obesity, achieving weight loss outcomes of up to 20-22%—results previously only possible with bariatric surgery.
💡 What You'll Gain: ✅ Latest scientific updates on incretin-based therapies ✅ Real-world clinical experience from leading experts ✅ Interactive case discussions and Q&A sessions ✅ Practical strategies for implementation in your practice ✅ Networking with colleagues from across the region ✅ CME credits upon completion
🌐 Language: Conference conducted in English with Russian interpretation throughout
This is your opportunity to master these game-changing therapies and improve patient outcomes in your practice.
👉 Register now: www.aop.am/conference